Melhores Cancro do fígado Cancro do fígado em Israel - TOP-20 médicos

A Dra. Pelles Sharon é especialista em tratamentos avançados de cancro do fígado no Sourasky Medical Center, incluindo quimioterapia e terapias direcionadas. Contribui ativamente para a investigação oncológica, garantindo cuidados ao paciente baseados em evidências.

• Realizar resseções hepáticas e quimioembolização para cancro do fígado
• Ser especialista em terapia direcionada e abordagens de imunoterapia
• Realizar pesquisas sobre as atitudes dos pacientes em relação a ensaios clínicos

O Prof. Merimsky chefia a unidade de sarcoma no Sourasky Medical Center, trazendo profunda experiência no tratamento do cancro do fígado com mais de 30 anos de prática.

• Especialista em oncologia de tecidos moles e ósseos
• Membro do corpo docente da ESMO para sarcoma
• Ex-Presidente de Oncologia na Universidade de Tel-Aviv
• Extensa investigação em imunologia tumoral

O Prof. Arber especializa-se na prevenção e no diagnóstico de cancros gastrointestinais, e não apenas no seu tratamento. Ele dirige o Centro de Prevenção do Cancro no Sourasky Medical Center.

• Mais de 30 anos de experiência em oncologia gastrointestinal
• Publicação de mais de 300 artigos de investigação sobre cancros gastrointestinais
• Dirigir o Centro de Prevenção do Cancro no Ichilov
• Bolsa de estudo e experiência de investigação num hospital de topo nos EUA
• Membro de sociedades de investigação oncológica internacionais de renome

Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.

He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.

He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.

Prof. Ido Nachmany heads the Second Surgical Department at Sheba Medical Center. He specializes in HPB and robotic surgery for diseases of the liver, pancreas, and bile ducts, and for gastrointestinal neuroendocrine tumors. He also performs adrenal, spleen, and stomach surgery. Forbes listed him among Israel’s top physicians.

He advances minimally invasive robotic and laparoscopic techniques. The aim is better precision and faster recovery.

Credentials: Senior Lecturer at Tel Aviv University. Member of ASTS and IHPBA. Completed HPB and abdominal transplant fellowships at the Thomas E. Starzl Transplantation Institute. Board certified in General Surgery (Israel), Abdominal Organ Transplantation (ASTS), and HPB Surgery (University of Pittsburgh). He has published in Cancer Research, the Journal of the American College of Surgeons, and the European Journal of Surgical Oncology.

Dr. Einat Shacham‑Shmueli is a senior medical oncologist at the Gastrointestinal Clinic, Cancer Center, Sheba Medical Center. She treats cancers of the colon, stomach, and pancreas. She also manages metastatic disease. She uses precision diagnostics and biomarkers, systemic therapies, and radiotherapy. Care is provided within a multidisciplinary team.

She has authored more than 25 peer‑reviewed papers on GI oncology, tumor biology, and new treatments. Her work includes studies on stenting for malignant colonic obstruction. She serves as an investigator in international programs, including the NCI, the Radiation Therapy Oncology Group, and the Cancer Therapy Evaluation Program.

Education: MD, Tel Aviv University. Oncology residency, Tel Aviv Sourasky Medical Center. Advanced training in GI oncology, UCSF. Accreditations: Board certified in Oncology and Gastroenterology. Member, Israel Society of Oncology and Radiotherapy.

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

Dr. Almog Ben-Yaacov is an Attending Surgeon in the Department of General and Oncological Surgery (Surgery C) at Sheba Medical Center. He specializes in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). His clinical focus includes gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, he has performed more than 200 HIPEC procedures.

MD, Semmelweis University, 2006, with honors. Training in cardiothoracic surgery at Sheba Medical Center. Residency in general surgery at Montefiore (Albert Einstein) and at Rabin (Beilinson). Board-certified in General Surgery and in Surgical Oncology.

Advanced training includes ESSO-certified HIPEC in Hamburg. Microwave liver ablation in Reims. NanoKnife at King’s College London. Advanced surgical oncology at Memorial Sloan Kettering (2019). His publications cover CRS+HIPEC outcomes and Hartmann’s reversal.

Chefe da divisão de oncologia no principal centro médico Sourasky de Tel Aviv – O Prof. Wolf lidera uma equipe de alto nível.

• Especialização em oncologia médica e medicina interna no centro médico Sheba
• Conclusão de uma bolsa de pós-doutorado no centro médico Cedar-Sinai da UCLA
• Membro das principais sociedades de oncologia, incluindo ASCO e AACR
• Professor sênior na Faculdade de Medicina Sackler da Universidade de Tel-Aviv

O Dr. Ron Greenberg é um cirurgião abdominal de renome que realiza procedimentos de Whipple, tanto abertos quanto minimamente invasivos, para o câncer de fígado.

• Ter mais de 20 anos de experiência cirúrgica
• Chefiar o Departamento de Cirurgia Colorretal no Sourasky Medical Center
• Ser especialista em procedimentos complexos, incluindo a técnica de Whipple

Mais de 28 anos de experiência no tratamento de cancros do fígado e gastrointestinais – o Dr. Ben-haim é especialista em oncologia cirúrgica complexa no Sourasky Medical Center.

• Especialista em cirurgia de Whipple para cancro do pâncreas
• Focado exclusivamente em oncologia gastrointestinal
• Realizar intervenções avançadas para tumores hepáticos

Um dos melhores cirurgiões de Whipple em Israel, o Dr. Klauzner é especializado em procedimentos gastrointestinais e pancreáticos complexos. Atualmente, ele chefia o Departamento de Cirurgia do Sourasky Medical Center (Ichilov).

• Mais de 45 anos de experiência cirúrgica
• Especialista em cirurgias de cancro do fígado, colorretal e pâncreas
• Especialização no complexo procedimento de Whipple
• Exercer um cargo de liderança sénior num grande centro médico académico

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

O Dr. Alexander Beny lidera o Serviço de Malignidade Gastrointestinal no Rambam Medical Center, especializando-se no tratamento do cancro do fígado.

• Oncologista certificado com formação em oncologia médica e radioterapia
• Especialista em oncologia gastrointestinal – dirige uma clínica oncológica dedicada
• Formado em técnicas modernas de braquiterapia na ESTRO
• Fluente em inglês e hebraico para pacientes internacionais

O Professor Rifaat Safadi especializa-se no tratamento de doenças hepáticas como chefe da unidade de doenças hepáticas no Hadassah Medical Center. O seu trabalho inclui a imunomodulação da fibrose hepática.

• Mais de 30 anos de experiência em gastroenterologia e hepatologia
• Estágio na Sinai School of Medicine com o Professor Scott Friedman, especialista em doenças hepáticas
• Vencedor de múltiplos prémios pela investigação em fibrose hepática
• Autor de numerosos artigos e membro de associações internacionais para o estudo do fígado
• Membro do conselho editorial da revista Clinical Science

Chefe do Instituto de Oncologia desde 1994 – Tamar Jablonski-Perec lidera o atendimento oncológico no Hadassah Medical Center com décadas de experiência.

• Especialização no tratamento de câncer de fígado com formação internacional
• Professora de Oncologia na Universidade Hebraica
• Membro de múltiplas comunidades internacionais de câncer
• Premiada com a prestigiosa bolsa da Hadassah Medical School

A Dra. Zalmanova é especialista em radioterapia para cancro do fígado no Assuta Medical Center, um hospital de referência em Israel.

• Experiência focada em tratamentos de radioterapia
• Trabalhar numa instalação médica de primeira linha
• Dedicar-se ao atendimento personalizado ao paciente

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.